Results 111 to 120 of about 1,701 (184)

Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention. [PDF]

AIDS
Rodrigues K, Bahrambegi R, Reid M.
europepmc   +1 more source

Resistance Analysis of Weekly Islatravir Plus Lenacapavir in People With HIV at 48 Weeks. [PDF]

J Acquir Immune Defic Syndr
VanderVeen LA, Selzer L, Chang S, Li J, Diamond TL, Asante-Appiah E, Llamoso C, Rhee MS, Callebaut C.   +8 more
europepmc   +1 more source

Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis

xi, 47 p.This publication provides evidence-based recommendations on the use of long-acting injectable lenacapavir for HIV prevention and on HIV testing strategies to support the delivery of long-acting pre-exposure prophylaxis (PrEP).
World Health Organization
core  

Agreements to provide affordable lenacapavir

The Lancet Microbe
openaire   +2 more sources

Optimising scale-up of injectable lenacapavir for HIV pre-exposure prophylaxis in South Africa: A modelling study and economic evaluation. [PDF]

PLoS Med
Jamieson L, Johnson LF, Imai-Eaton JW, Subedar H, Bekker LG, Meyer-Rath G.   +5 more
europepmc   +1 more source

A Phase 1 Study to Evaluate the Potential Drug-Drug Interaction Between Islatravir and Lenacapavir. [PDF]

J Clin Pharmacol
Zhang H, West S, Kwok N, Mkaya C, Ling J, Palaparthy R, Longo D, Gillespie G, Llamoso C, Rhee M, Marathe DD.   +10 more
europepmc   +1 more source

Long-Acting Cabotegravir Injections Are More Acceptable Than Long-Acting Lenacapavir Injections After One Dose: Results From the CLARITY Randomized Crossover Study. [PDF]

Adv Ther
Elliot ER, Boles J, Fox D, Nelson KL, Dupont-Benjamin L, Vutikullird A, Mottola A, Fletcher K, Wang K, Somvanshi S, Grove R, Strano K, Pilgrim N, Borsi R, Budnik P, van Wyk J, Garges HP, Brown K.   +17 more
europepmc   +1 more source

Evaluation of Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet of Islatravir and Lenacapavir. [PDF]

J Clin Pharmacol
Niu J, Zhang H, Ling J, Madera S, Kwok N, West S, Longo D, Gillespie G, Llamoso C, Marathe DD.   +9 more
europepmc   +1 more source

Virologic Outcomes With Lenacapavir in People With Human Immunodeficiency Virus: A Multicenter Real-World Study. [PDF]

Open Forum Infect Dis
Kaperak C, Li Y, Sha B, Mercon M, Montes K, Sanes Guevara M, Shankaran S, Aziz M, Creticos C, Glick N, Hunt BR, Sam S, Djuricich P, Merker A, Hazra A.   +14 more
europepmc   +1 more source